Litcius/Paper detail

Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency

James Verbsky, Mary Hintermeyer, Pippa Simpson, Mingen Feng, Jody Barbeau, Nagarjun Rao, Carlyne D. Cool, Luis Antonio Sosa-Lozano, Dhiraj Baruah, Erin Hammelev, Alyssa Busalacchi, Amy L. Rymaszewski, J Woodliff, Shaoying Chen, Mary T. Bausch-Jurken, John M. Routes

2020Journal of Allergy and Clinical Immunology67 citationsDOI

Topics & Concepts

Common variable immunodeficiencyRituximabMedicineAntimetaboliteInterstitial lung diseaseGranulomatous diseaseImmunologyLungDiseasePathologyLymphomaInternal medicineAntibodyMethotrexateImmunodeficiency and Autoimmune DisordersCancer Immunotherapy and BiomarkersMycobacterium research and diagnosis
Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency | Litcius